Skip to main content
. 2018 Sep 2;8(3):62. doi: 10.3390/diagnostics8030062

Figure 1.

Figure 1

Characteristic molecular alterations in different stages of prostate cancer. Inactivation is markedly observed in castration-resistant (CR) * and neuroendocrine (NE) ** tumors. Genetic alterations in the DNA damage repair pathways are increased in CR but are almost absent in NE tumors. AR = androgen receptor; LBD = ligand binding domain.